title: Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice.
abstract: Like interleukin-1, recombinant human tumor necrosis factor alpha (TNF alpha) has been found to decrease social exploration and induce weight loss in mice in a dose and time-dependent manner. The present study was carried out to study the interaction between these two cytokines. Mice were injected IP with subthreshold doses of TNF alpha (2.5 micrograms/mouse) and IL-1 beta (50 ng/mouse). Social exploration was decreased 2 and 4 h after injection of TNF and IL-1, but body weight was not affected. Subthreshold doses of TNF alpha (90 ng/mouse) and IL-1 beta (100 pg/mouse) were also injected intracerebroventricularly (ICV). Social exploration was decreased 1.5 and 3 h after injections of the two cytokines and body weight was decreased for 6 h. To test the possibility of central induction of IL-1 by TNF alpha, mice pretreated with IL-1 receptor antagonist (IL-1ra, 1.8 micrograms/mouse, ICV) were injected with 90 ng TNF alpha. Pretreatment with IL-1ra antagonized the depressive effect of TNF alpha on behavior, but had no effect on weight loss induced by this cytokine. These results suggest that TNF alpha-induced behavioral alterations are mediated by endogenously released IL-1, whereas metabolic changes are dependent on the release of other cytokines.
authors.affiliation: INRA-INSERM U394, Bordeaux, France.
authors.forename: R M
authors.initials: RM
authors.lastname: Bluthé
authors.forename: M
authors.initials: M
authors.lastname: Pawlowski
authors.forename: S
authors.initials: S
authors.lastname: Suarez
authors.forename: P
authors.initials: P
authors.lastname: Parnet
authors.forename: Q
authors.initials: Q
authors.lastname: Pittman
authors.forename: K W
authors.initials: KW
authors.lastname: Kelley
authors.forename: R
authors.initials: R
authors.lastname: Dantzer
mesh_terms: D000818:Animals; D001143:Arousal / Q000187:drug effects*; D001835:Body Weight; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005106:Exploratory Behavior / Q000187:drug effects*; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D011994:Recombinant Proteins / Q000494:pharmacology; D012795:Sialoglycoproteins / Q000494:pharmacology; D012919:Social Behavior; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: C507763:IL1RN protein, human; C507764:Il1rn protein, mouse; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D011994:Recombinant Proteins; D012795:Sialoglycoproteins; D014409:Tumor Necrosis Factor-alpha